Pioglitazone Protects Mesenchymal Stem Cells against P-Cresol-Induced Mitochondrial Dysfunction via Up-Regulation of PINK-1
暂无分享,去创建一个
J. H. Lee | C. Yun | Sang Hun Lee | Y. Yoon | Yong-seok Han | Rang A Kim | Yong-Seok Han
[1] J. H. Lee,et al. Pioglitazone Improves the Function of Human Mesenchymal Stem Cells in Chronic Kidney Disease Patients , 2019, International journal of molecular sciences.
[2] C. Yun,et al. Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease , 2019, International journal of molecular sciences.
[3] J. H. Lee,et al. TUDCA-Treated Mesenchymal Stem Cells Protect against ER Stress in the Hippocampus of a Murine Chronic Kidney Disease Model , 2019, International journal of molecular sciences.
[4] J. H. Lee,et al. Co-Administration of Melatonin Effectively Enhances the Therapeutic Effects of Pioglitazone on Mesenchymal Stem Cells Undergoing Indoxyl Sulfate-Induced Senescence through Modulation of Cellular Prion Protein Expression , 2018, International journal of molecular sciences.
[5] J. H. Lee,et al. Fucoidan Rescues p-Cresol-Induced Cellular Senescence in Mesenchymal Stem Cells via FAK-Akt-TWIST Axis , 2018, Marine drugs.
[6] J. Forbes,et al. Mitochondrial dysfunction in diabetic kidney disease , 2018, Nature Reviews Nephrology.
[7] S. Yun,et al. Tauroursodeoxycholic Acid Protects against the Effects of P-Cresol-Induced Reactive Oxygen Species via the Expression of Cellular Prion Protein , 2018, International journal of molecular sciences.
[8] D. Galvan,et al. The hallmarks of mitochondrial dysfunction in chronic kidney disease. , 2017, Kidney international.
[9] M. Cheng,et al. Protein-bound uremic toxins impaired mitochondrial dynamics and functions , 2017, Oncotarget.
[10] H. Han,et al. Enhancement of high glucose‐induced PINK1 expression by melatonin stimulates neuronal cell survival: Involvement of MT2/Akt/NF‐κB pathway , 2017, Journal of pineal research.
[11] Mark Ellisman,et al. Pink1 and Parkin regulate Drosophila intestinal stem cell proliferation during stress and aging , 2017, The Journal of cell biology.
[12] G. Qin,et al. FoxO1 Promotes Mitophagy in the Podocytes of Diabetic Male Mice via the PINK1/Parkin Pathway , 2017, Endocrinology.
[13] R. Tian,et al. Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes , 2017, Stem cells international.
[14] Chi Ma,et al. Pioglitazone inhibits advanced glycation end product-induced matrix metalloproteinases and apoptosis by suppressing the activation of MAPK and NF-κB , 2016, Apoptosis.
[15] J. M. Ryu,et al. Fucoidan improves bioactivity and vasculogenic potential of mesenchymal stem cells in murine hind limb ischemia associated with chronic kidney disease. , 2016, Journal of molecular and cellular cardiology.
[16] R. Stratta,et al. Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair , 2016, Expert review of clinical immunology.
[17] R. Malekzadeh,et al. Repeated Intraportal Injection of Mesenchymal Stem Cells in Combination with Pioglitazone in Patients with Compensated Cirrhosis: A Clinical Report of Two Cases. , 2016, Archives of Iranian medicine.
[18] Nektarios Tavernarakis,et al. Mitophagy: In sickness and in health , 2016, Molecular & cellular oncology.
[19] C. Reutelingsperger,et al. Vascular calcification in chronic kidney disease: an update. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] Janet S. Lee,et al. PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. , 2015, The Journal of clinical investigation.
[21] B. Lisowska-Myjak. Uremic Toxins and Their Effects on Multiple Organ Systems , 2014, Nephron Clinical Practice.
[22] Jia Liu,et al. Cell-based Therapy for Acute Organ Injury: Preclinical Evidence and Ongoing Clinical Trials Using Mesenchymal Stem Cells , 2014, Anesthesiology.
[23] L. Pączek,et al. Uremic toxins impair human bone marrow-derived mesenchymal stem cells functionality in vitro. , 2014, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[24] K. Verbeke,et al. Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease , 2014, BMC Nephrology.
[25] R. Tuan,et al. Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells , 2014, Stem cells.
[26] J. I. Izpisúa Belmonte,et al. Mitochondrial regulation in pluripotent stem cells. , 2013, Cell metabolism.
[27] S. Bhatia,et al. Mitochondrial localization and the persistent migration of epithelial cancer cells. , 2013, Biophysical journal.
[28] Huifeng Zhang,et al. PPAR‐γ agonist pioglitazone prevents apoptosis of endothelial progenitor cells from rat bone marrow , 2013, Cell biology international.
[29] Lin Sun,et al. Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology , 2012, Kidney international.
[30] R. Vanholder,et al. Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration. , 2013, Biochimica et biophysica acta.
[31] Å. Gustafsson,et al. Mitochondria and Mitophagy: The Yin and Yang of Cell Death Control , 2012, Circulation research.
[32] J. Poderoso,et al. Mitochondrial regulation of cell cycle and proliferation. , 2012, Antioxidants & redox signaling.
[33] Kindiya D. Geghman,et al. Pink1 regulates the oxidative phosphorylation machinery via mitochondrial fission , 2011, Proceedings of the National Academy of Sciences.
[34] Arnold I Caplan,et al. The MSC: an injury drugstore. , 2011, Cell stem cell.
[35] N. Zhang,et al. Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation , 2011, Basic Research in Cardiology.
[36] G. Bing,et al. Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury , 2011, Experimental Neurology.
[37] K. Verbeke,et al. p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[38] Michael P. Murphy,et al. How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.
[39] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[40] Yidong Bai,et al. Cytochrome c oxidase subunit IV is essential for assembly and respiratory function of the enzyme complex , 2006, Journal of bioenergetics and biomembranes.
[41] M. Little,et al. Regrow or Repair: Potential Regenerative Therapies for the Kidney Regenerative Approaches to Renal Disease Setting the Stage: Normal Kidney Development and Regeneration in Vertebrates , 2022 .
[42] R. Vanholder,et al. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. , 2004, Kidney international.
[43] Bertram L Kasiske,et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.